The Authors’ Reply: Comment on “Healthy Decisions: Towards Uncertainty Tolerance in Healthcare Policy”

@article{Grutters2015TheAR,
  title={The Authors’ Reply: Comment on “Healthy Decisions: Towards Uncertainty Tolerance in Healthcare Policy”},
  author={Janneke Grutters and Marjolein B. A. van Asselt and K. Chalkidou and Manuela M A Joore},
  journal={PharmacoEconomics},
  year={2015},
  volume={33},
  pages={983-983}
}
In his response to our article, Afschin Gandjour refers to the German approach towards healthcare policy decisions, which has been criticized in the past [1]. He states that in this approach, one specific form of ambiguity (or ‘recognised ignorance’), the potential arrival of new treatments in the future, is cancelled out. In conceptualizing uncertainty, the author refers to the work by Luce and Raiffa, who distinguish risk and ambiguity [2]. We used the work by Walker et al. to emphasize that… CONTINUE READING